These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19861353)

  • 21. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk reduction by preventing stroke: need for blockade of angiotensin II and catecholamines?
    Rupp H
    Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S25-9. PubMed ID: 18093411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The angiotensin II type 2 receptor in renal disease.
    Wenzel UO; Krebs C; Benndorf R
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):37-41. PubMed ID: 19861345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M
    Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
    Banks T; Oyekan A
    J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
    Oprisiu-Fournier R; Faure S; Mazouz H; Boutitie F; Serot JM; Achard JM; Godefroy O; Hanon O; Temmar M; Albu A; Strandgaard S; Wang J; Black SE; Fournier A
    Expert Rev Neurother; 2009 Sep; 9(9):1289-305. PubMed ID: 19769445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain.
    Miyamoto N; Zhang N; Tanaka R; Liu M; Hattori N; Urabe T
    Neurosci Res; 2008 Jul; 61(3):249-56. PubMed ID: 18455256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.
    Iwai M; Liu HW; Chen R; Ide A; Okamoto S; Hata R; Sakanaka M; Shiuchi T; Horiuchi M
    Circulation; 2004 Aug; 110(7):843-8. PubMed ID: 15289370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin receptor blockers and cerebral protection in stroke.
    Thöne-Reineke C; Steckelings UM; Unger T
    J Hypertens Suppl; 2006 Mar; 24(1):S115-21. PubMed ID: 16601564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The angiotensin II type 2 receptor in cardiovascular disease.
    Lemarié CA; Schiffrin EL
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):19-31. PubMed ID: 19861349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.
    Horiuchi M; Mogi M
    Br J Pharmacol; 2011 Jul; 163(6):1122-30. PubMed ID: 21175580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The angiotensin II type 2 receptor and the gastrointestinal tract.
    Fändriks L
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):43-8. PubMed ID: 19861352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Could angiotensin II type I receptor antagonists have a superior beneficial effect than that of angiotensin II converting enzyme inhibitors with respect to the risk of cerebrovascular accident?].
    Fournier A; Achard JM; Mazouz H; Pruna A; Hottelart C; Rosa A; Fernandez L; Andrejak M
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):997-1000. PubMed ID: 10486653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation.
    Schulz R; Heusch G
    J Hypertens Suppl; 2006 Mar; 24(1):S123-9. PubMed ID: 16601565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology, pathophysiology, and treatment of hypertension in ischaemic stroke patients.
    Hisham NF; Bayraktutan U
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e4-14. PubMed ID: 22682972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment.
    Füchtemeier M; Brinckmann MP; Foddis M; Kunz A; Po C; Curato C; Dirnagl U; Farr TD
    J Cereb Blood Flow Metab; 2015 Mar; 35(3):476-84. PubMed ID: 25492118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of Brain Angiotensin II in Cognitive Function and Dementia.
    Mogi M; Iwanami J; Horiuchi M
    Int J Hypertens; 2012; 2012():169649. PubMed ID: 23304450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection after ischemic stroke by activation of angiotensin receptor type 2: why clinical data do not fit the paradigm?
    Thorin E; Castoldi G; Stella A
    J Hypertens; 2015 Jan; 33(1):66-8. PubMed ID: 25470121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.